Advertisement

Topics

Valeant Said to Keep Salix After Takeda Deal Falls Apart

16:40 EST 1 Dec 2016 | Topix

Valeant Pharmaceuticals International Inc. has decided to keep and invest in its gastrointestinal-drugs division after talks to sell the unit to Takeda Pharmaceutical Co. fell apart, according to people familiar with the matter.

Original Article: Valeant Said to Keep Salix After Takeda Deal Falls Apart

NEXT ARTICLE

More From BioPortfolio on "Valeant Said to Keep Salix After Takeda Deal Falls Apart"

Quick Search
Advertisement